Carrie Partlan

Carrie Partlan is an accomplished professional with a diverse educational background and a wealth of experience in the pharmaceutical and biotechnology industry.

Carrie holds an MBA from MIT Sloan School of Management, a D.Phil. from the University of Oxford, and a B.Sc. from the Massachusetts Institute of Technology, showcasing her strong academic foundation.

Her career includes pivotal roles such as Director of Commercial Planning at Takeda, where she excels in strategic decision-making and operational excellence.

Previously, Carrie served as the Associate Director of Strategy & Portfolio Analytics at Alnylam Pharmaceuticals and has held notable positions at Bioverativ, Equinox Group, and Sunovion Pharmaceuticals Inc., where she led in financial planning, analysis, and commercial analytics.

With experience working at esteemed organizations like Genzyme Corporation, Pfizer, Inc., and General Electric Aircraft Engines, Carrie has honed her skills in corporate development, consulting, and strategic management.

Carrie's expertise spans across various domains including finance, corporate strategy, commercial planning, and decision sciences, making her a versatile professional in the pharmaceutical industry.

She brings a unique perspective to each role, leveraging her comprehensive background in academia and her hands-on experience to drive innovation and success in her endeavors.